The consensus EPS estimate for the quarter has undergone a downward revision of 0.9% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe. In light of this perspective, let's dive into the average estimates of certain Xylem metrics that are commonly tracked and forecasted by Wall Street analysts. Analysts forecast 'Revenue- Measurement & Control Solutions' to reach $470.39 million. The esti ...

Let's see how things have shaped up for Xylem this earnings season. Growth in the transport application business, driven by backlog execution and the timing of projects in Western Europe, is expected to have boosted the Water Infrastructure segment's performance. The Water Solutions and Services segment is anticipated to have performed strongly, driven by strength in the dewatering application business. Earnings Whispers The company has a stellar earnings surprise history, having outperformed the Zacks Cons ...

Company Overview - Xylem (XYL) is expected to report quarterly earnings of $1.06 per share, reflecting a year-over-year increase of +8.2% [4] - Revenues are anticipated to reach $2.16 billion, representing a 25.2% increase from the same quarter last year [5] Earnings Expectations - The market consensus indicates a year-over-year increase in earnings driven by higher revenues for Xylem's upcoming report [2] - The consensus EPS estimate has been revised down by 0.88% over the last 30 days, indicating a reassessment by analysts [5] Earnings Surprise Prediction - Xylem's Earnings ESP (Expected Surprise Prediction) is currently at -1.62%, suggesting a bearish outlook from analysts [16] - A positive Earnings ESP is generally a strong predictor of an earnings beat, particularly when combined with a favorable Zacks Rank [8] Historical Performance - Over the last four quarters, Xylem has consistently beaten consensus EPS estimates [10] - In the last reported quarter, Xylem was expected to post earnings of $0.84 per share but exceeded expectations with earnings of $0.90, resulting in a surprise of +7.14% [18] Industry Context - Flowserve (FLS), another player in the same industry, is expected to report earnings of $0.63 per share, indicating a year-over-year change of +21.2% [25] - Flowserve's revenues for the quarter are projected to be $1.12 billion, up 3.9% from the previous year [25]

CAMBRIDGE, Mass., July 9, 2024 /PRNewswire/ -- Sense, the leader in embedded intelligence that transforms the relationship between people, homes, and the grid, and the Sensus team of Xylem (NYSE: XYL), which provides remotely-managed products and solutions for investor-owned utilities, cooperatives, and municipalities, are collaborating on what is expected to be the first electric meter capable of capturing and processing 1 MHz data in North America. The increase in fidelity from the high-resolution data (1 ...

[PART I – Financial Information](index=4&type=section&id=PART%20I%20%E2%80%93%20Financial%20Information) [Item 1. Financial Statements](index=4&type=section&id=Item%201.%20Financial%20Statements) The company reported strong Q1 2024 financial results, with revenue up 40.4% to $2.03 billion and net income increasing to $153 million, significantly impacted by the Evoqua acquisition Condensed Consolidated Income Statement Highlights (Q1 2024 vs Q1 2023) | Metric | Q1 2024 (in millions) | Q1 2023 (in millions) | Change | | :--- | :--- | :--- | :--- | | **Revenue** | $2,033 | $1,448 | +40.4% | | **Gross Profit** | $752 | $546 | +37.7% | | **Operating Income** | $209 | $131 | +59.5% | | **Net Income** | $153 | $99 | +54.5% | | **Diluted EPS** | $0.63 | $0.54 | +16.7% | Condensed Consolidated Balance Sheet Highlights (As of March 31, 2024) | Metric | March 31, 2024 (in millions) | December 31, 2023 (in millions) | | :--- | :--- | :--- | | Cash and cash equivalents | $947 | $1,019 | | Goodwill | $7,509 | $7,587 | | Total Assets | $15,924 | $16,112 | | Total Liabilities | $5,721 | $5,936 | | Total Equity | $10,203 | $10,176 | Condensed Consolidated Statement of Cash Flows Highlights (Q1 2024 vs Q1 2023) | Metric | Q1 2024 (in millions) | Q1 2023 (in millions) | | :--- | :--- | :--- | | Net Cash – Operating activities | $89 | $(19) | | Net Cash – Investing activities | $(51) | $(37) | | Net Cash – Financing activities | $(82) | $(63) | | Net change in cash | $(72) | $(107) | [Notes to the Condensed Consolidated Financial Statements (Unaudited)](index=8&type=section&id=Notes%20to%20the%20Condensed%20Consolidated%20Financial%20Statements%20(Unaudited)) Notes detail accounting policies, the Evoqua acquisition's impact, segment realignment, and debt structure, including $9 million in restructuring charges - Effective January 1, 2024, the company changed its reportable segments to Water Infrastructure, Applied Water, Measurement and Control Solutions, and Water Solutions and Services, with prior periods recast for comparability[23](index=23&type=chunk) - The **Evoqua acquisition** on May 24, 2023, for **$6.9 billion**, resulted in **$4.8 billion in goodwill** and contributed **$480 million in Q1 2024 revenue** and **$6 million in income before taxes**[29](index=29&type=chunk)[30](index=30&type=chunk)[34](index=34&type=chunk) Revenue from Contracts with Customers by Segment (Q1 2024 vs Q1 2023) | Segment | Q1 2024 (in millions) | Q1 2023 (in millions) | | :--- | :--- | :--- | | Water Infrastructure | $574 | $410 | | Applied Water | $436 | $453 | | Measurement and Control Solutions | $462 | $378 | | Water Solutions and Services | $561 | $207 | | **Total** | **$2,033** | **$1,448** | - In Q1 2024, the company incurred **$9 million in restructuring costs**, primarily for headcount reduction related to Evoqua integration[44](index=44&type=chunk) [Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations](index=34&type=section&id=Item%202.%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management reported strong Q1 2024 results with 40.4% revenue growth to $2.03 billion, 43.1% order growth, and an updated full-year 2024 outlook Q1 2024 Financial Highlights | Metric | Q1 2024 | Change vs. Q1 2023 | | :--- | :--- | :--- | | Revenue | $2,033 million | +40.4% | | Organic Revenue Growth | 7.1% | - | | Orders | $2,246 million | +43.1% | | Organic Orders Growth | 3.4% | - | | Diluted EPS | $0.63 | +16.7% | | Adjusted Diluted EPS | $0.90 | +13.9% | | Adjusted EBITDA Margin | 19.2% | +290 bps | - The company updated its full-year 2024 outlook, projecting total revenue growth between **15% and 16%** and organic revenue growth between **4% and 6%**[183](index=183&type=chunk) - Total backlog increased to **$5.3 billion** at the end of Q1 2024, a **40.8% increase** year-over-year, with **$1.4 billion from acquired backlog**, and **45% expected to be recognized in 2024**[147](index=147&type=chunk) [Results of Operations](index=39&type=section&id=Results%20of%20Operations) Q1 2024 total revenue increased 40.4% to $2.03 billion, driven by acquisitions and organic growth, while gross margin slightly decreased and operating margin expanded Q1 2024 Revenue Growth Breakdown by Segment | Segment | Total Change | Organic Growth | Acquisitions | FX Impact | | :--- | :--- | :--- | :--- | :--- | | Water Infrastructure | +40.0% | +6.3% | +33.4% | +0.2% | | Applied Water | -3.8% | -4.0% | 0.0% | +0.2% | | Measurement & Control Solutions | +22.2% | +22.0% | 0.0% | +0.3% | | Water Solutions & Services | +171.0% | +5.8% | +165.7% | -0.5% | | **Total Xylem** | **+40.4%** | **+7.1%** | **+33.1%** | **+0.1%** | - Gross margin decreased by **70 basis points to 37.0%**, primarily due to **special charges and inflation**, partially offset by **productivity savings and price realization**[148](index=148&type=chunk) - Operating margin increased by **130 basis points to 10.3%**, driven by **productivity savings, price realization, and increased volumes**, partially offset by **inflation and strategic investment costs**[154](index=154&type=chunk) [Liquidity and Capital Resources](index=50&type=section&id=Liquidity%20and%20Capital%20Resources) The company maintains strong liquidity with $1.9 billion available, driven by improved operating cash flow and increased cash usage in financing activities - The company has available liquidity of approximately **$1.9 billion**, comprising **$947 million in cash** and **$1 billion in available credit facilities**[179](index=179&type=chunk) - Net cash provided by operating activities improved to **$89 million** in Q1 2024 from a **$19 million use** in Q1 2023, primarily due to **higher cash earnings**[172](index=172&type=chunk)[173](index=173&type=chunk) - Cash used in financing activities increased to **$82 million** from **$63 million** year-over-year, due to **higher dividend payments and increased share repurchases**[175](index=175&type=chunk) [Item 3. Quantitative and Qualitative Disclosures About Market Risk](index=51&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) No material changes in market risk disclosures were reported since the 2023 Annual Report on Form 10-K - There has been **no material change** in market risk disclosures since the **2023 Annual Report**[184](index=184&type=chunk) [Item 4. Controls and Procedures](index=51&type=section&id=Item%204.%20Controls%20and%20Procedures) Management concluded disclosure controls and procedures were effective, with no material changes to internal control over financial reporting - The CEO and CFO concluded that the company's **disclosure controls and procedures were effective** as of the end of the reporting period[185](index=185&type=chunk) - **No material changes** in internal control over financial reporting were identified during the fiscal quarter[186](index=186&type=chunk) [PART II – Other Information](index=52&type=section&id=PART%20II%20%E2%80%93%20Other%20Information) [Item 1. Legal Proceedings](index=52&type=section&id=Item%201.%20Legal%20Proceedings) The company is cooperating with an investigation into Evoqua's past financial filings, not expecting a material adverse effect - The company is cooperating with a U.S. Attorney's Office investigation regarding **potential financial misstatements in Evoqua's historical public filings**[189](index=189&type=chunk) - Management currently believes the Evoqua investigation will **not have a material adverse effect** on the company's financial condition or operations[189](index=189&type=chunk) [Item 1A. Risk Factors](index=52&type=section&id=Item%201A.%20Risk%20Factors) No material changes to risk factors were reported compared to those disclosed in the 2023 Annual Report on Form 10-K - **No material changes** to risk factors were reported compared to those disclosed in the **2023 Annual Report**[191](index=191&type=chunk) [Item 2. Unregistered Sales of Equity Securities and Use of Proceeds](index=52&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) The company did not repurchase shares in Q1 2024, with approximately $182 million remaining under the existing share repurchase authorization - **No shares were repurchased** under the company's publicly announced plan during the first quarter of 2024[192](index=192&type=chunk)[194](index=194&type=chunk) - As of March 31, 2024, **$182 million remains available** for share repurchases under the existing authorization from August 2015[194](index=194&type=chunk)

Financial Data and Key Metrics Changes - Xylem reported a strong first quarter with total revenues growing by 40% and organic revenues rising by 7%, exceeding guidance [15][23] - Adjusted EBITDA margin increased to 19.2%, up 290 basis points from the prior year, driven by productivity savings and strong volume [15][16] - Earnings per share (EPS) for the quarter was $0.90, reflecting a 14% increase year-over-year [16] Business Line Data and Key Metrics Changes - Measurement & Control Solutions (M&CS) saw organic revenue growth of over 20% with EBITDA margins up 550 basis points year-over-year [9][18] - Water Solutions and Services (WSS) achieved the highest orders growth among all segments, with organic revenue up 6% and pro forma revenue increasing by 9% [21][22] - Water Infrastructure reported a total revenue growth of 40% and organic growth of 6%, driven by robust demand [19] Market Data and Key Metrics Changes - The backlog increased by 4% to $5.3 billion, with organic orders growing by 3% in the quarter [14][15] - Strong demand was noted across developed markets, particularly in the U.S., which experienced double-digit growth [15] Company Strategy and Development Direction - The company is focused on maximizing value from incremental volume and simplifying operations to enhance efficiency [11][12] - Xylem's strategic outlook is supported by secular trends in water security, with increasing demand for solutions that enhance water security [13] - An Investor Day is scheduled for May 30, where updates on strategic outlook and sustainability goals will be shared [14][32] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the operational momentum and resilient demand across most segments, despite monitoring macroeconomic factors like inflation and geopolitical uncertainty [27] - The company is raising its full-year guidance for revenue to approximately $8.5 billion, reflecting an additional point of growth [23][24] Other Important Information - The company is tracking well on cost synergies from the Evoqua acquisition, with expectations of around $100 million in exit rate cost synergies for 2024 [25] - Free cash flow conversion for the year is expected to be 115% of net income [25] Q&A Session Summary Question: Insights on Evoqua integration and revenue synergies - Management highlighted strong momentum in the Evoqua integration, with cost synergies tracking well and revenue synergies ramping up [35][36] Question: Focus on portfolio optimization and M&A opportunities - Management emphasized a focus on executing the platform built over the past decade, with a commitment to driving above-market growth [40][41] Question: Dynamics in orders and market trends - Management noted healthy demand across most end markets, with government funding supporting growth [51][52] Question: Update on IIJA related growth opportunities - Management indicated that government funding will trickle in over the next three to five years, supporting market growth [76] Question: Impact of new EPA rules regarding PFAS - Management stated that compliance timelines for utilities will take time, but Xylem is well-positioned to partner with utilities on PFAS solutions [70] Question: Margin performance in M&CS - Management reported significant margin expansion in M&CS due to productivity and pricing strategies [72][73]

xylem 2024 First Quarter Results & Earnings 0 Forward-Looking Statements This presentation contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Generally, the words "anticipate," "estimate," "expect," "project," "intend," "plan," "contemplate," "predict," "forecast," "likely," "believe," "target," "will," "could," "would," "should," "potential," "may" and similar expressions or t ...

Exhibit 99.1 Xylem Inc. 301 Water Street SE, Suite, 200 Washington, DC 20003 Tel +1.202.869.9150 1 • Orders of $2.2 billion, up 43% on a reported basis and 3% organically • Revenue of $2.0 billion, up 40% on a reported basis and 7% organically • Earnings per share of $0.63, up 17%; $0.90 on an adjusted basis, up 14% • Raising full-year revenue guidance to approximately $8.5B, up 15% to 16%, with organic revenue growth of 4% to 6%, up from 3% to 5% • Lifting full-year adjusted EPS guidance to $4.10 to $4.25, ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 1-35229 Xylem Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) ...

Xylem Inc. (NYSE:XYL) Q4 2023 Earnings Conference Call February 6, 2024 9:00 AM ET Company Participants Andrea van der Berg - Vice President, Investor Relations Matthew Pine - Chief Executive Officer Bill Grogan - Chief Financial Officer Conference Call Participants Deane Dray - RBC Capital Markets Mike Halloran - Robert W. Baird Scott Davis - Melius Research Andy Kaplowitz - Citigroup Nathan Jones - Stifel Nicolaus Joe Giordano - TD Cowen Operator Welcome to Xylem's Fourth Quarter 2023 Results Conference C ...